This past September 5, Jeanine Dick, the wife of Virbac’s founder, resigned from her position as vice-chairwoman of the supervisory board. Present since the early days of the company in 1968, Jeanine Dick also suggested to the members of the supervisory board that her granddaughter Solène (the eldest daughter of Marie-Hélène Dick and Pierre Madelpuech) should succeed her as a member of the Group’s supervisory board. Her appointment through co-option was approved at the board meeting held on September 5, 2017. On the same day, Pierre Madelpuech was appointed vice-chairman of the supervisory board.

Jeanine Dick: “I have been enthusiastically involved in Virbac’s development over the past 25 years. At 81 years of age, I suggested to my granddaughter Solène Madelpuech that she should succeed me. My family has deep ties to Virbac and the arrival of Solène as a 3rd generation family member is proof of our involvement over the long-term. I sincerely thank the executive board and all of the employees who have carried on this great adventure spearheaded by my husband some 50 years ago. I am very proud of the journey traveled and confident in the Group’s ability to further its development in the interests of animal health.”

Solène Madelpuech: “I am happy and honored to be joining the supervisory board of the company created by my grandfather and which has forever been a part of my life. Mindful of the involvement and enthusiasm of Virbac’s teams, I share their strong desire to assist in the pursuit of this extraordinary adventure. I thank my grandmother, my family and the members of the supervisory board for approving my appointment through co-option.”

The 24-year-old Solène Madelpuech graduated with a Bachelor of Business and Management from the Warwick Business School and a Masters in Management from the London Business School. Over the past year, she has been working as an analyst for a strategic consulting firm in London. The appointments through co-option of Solène Madelpuech and Pierre Madelpuech will be tabled for ratification at Virbac’s next shareholders’ meeting.

GO BACK